Table 2 Acylcarnitine profile in DCM patients
Variables | DCM | ST2DM | P |
|---|---|---|---|
Median (interquartile) | Median (interquartile) | ||
C0, μM | 30.95 (24.77–36.84) | 24.59 (20.45–31.54) | 0.002 |
C2, μM | 12.93 (10.43–16.40) | 10.76 (8.87–15.36) | 0.039 |
C3, μM | 1.87 (1.43–2.30) | 1.65 (1.13–2.18) | 0.119 |
C4, μM | 0.23 (0.16–0.34) | 0.19 (0.15–0.24) | 0.058 |
C4-OH, μM | 0.05 (0.03–0.10) | 0.05 (0.03–0.07) | 0.275 |
C4DC, μM | 0.41 (0.21–0.85) | 0.30 (0.24–0.41) | 0.088 |
C5, μM | 0.13 (0.09–0.16) | 0.14 (0.11–0.19) | 0.042 |
C5-OH, μM | 0.19 (0.13–0.28) | 0.18 (0.14–0.26) | 0.923 |
C5:1, μM | 0.03 (0.02–0.07) | 0.04 (0.02–0.06) | 0.774 |
C6, μM | 0.07 (0.06–0.09) | 0.07 (0.05–0.08) | 0.236 |
C8, μM | 0.11 (0.07–0.17) | 0.06 (0.04–0.08) | < 0.001 |
C10, μM | 0.16 (0.08–0.27) | 0.05 (0.03–0.07) | < 0.001 |
C12, μM | 0.08 (0.06–0.10) | 0.05 (0.03–0.07) | < 0.001 |
C14, μM | 0.08 (0.05–0.11) | 0.06 (0.04–0.08) | 0.002 |
C14-OH, μM | 0.04 (0.02–0.07) | 0.03 (0.02–0.04) | 0.016 |
C14DC, μM | 0.03 (0.02–0.05) | 0.02 (0.02–0.04) | 0.362 |
C16, μM | 1.02 (0.76–1.42) | 0.78 (0.62–0.92) | < 0.001 |
C16-OH, μM | 0.02 (0.02–0.03) | 0.02 (0.02–0.03) | 0.668 |
C16:1-OH, μM | 0.05 (0.03–0.07) | 0.04 (0.03–0.05) | 0.030 |
C18, μM | 0.54 (0.38–0.71) | 0.48 (0.36–0.59) | 0.133 |
C20, μM | 0.03 (0.02–0.05) | 0.02 (0.02–0.03) | 0.012 |
C22, μM | 0.06 (0.03–0.08) | 0.05 (0.04–0.07) | 0.319 |
C24, μM | 0.04 (0.03–0.06) | 0.03 (0.02–0.04) | 0.036 |
C26, μM | 0.03 (0.02–0.04) | 0.03 (0.02–0.04) | < 0.001 |
C14:1, μM | 0.10 (0.06–0.16) | 0.06 (0.03–0.08) | < 0.001 |